Skip to content

CRIB

CRIB

Center for Research Innovation in Biotechnology

  • Home
  • About CRIB
    • Michael S. Kinch
  • Publications
  • Books
    • A Prescription for Change
    • Between Hope and Fear
    • End of the Beginning
    • The Price of Health
  • News Stories
    • Op-Eds
    • Interviews
  • Contact Us
Washington University in St. Louis

CRIB

Center for Research Innovation in Biotechnology

CRIB

  • Home
  • About CRIB
    • Michael S. Kinch
  • Publications
  • Books
    • A Prescription for Change
    • Between Hope and Fear
    • End of the Beginning
    • The Price of Health
  • News Stories
    • Op-Eds
    • Interviews
  • Contact Us
  • Publication

An analysis of FDA-approved drugs: natural products and their derivatives. – PubMed – NCBI

by Michael Kinch · Published February 1, 2016 · Updated February 1, 2016

Drug Discov Today. 2015 Jan 21. pii: S1359-6446(15)00031-8. doi: 10.1016/j.drudis.2015.01.009. [Epub ahead of print]
Source: An analysis of FDA-approved drugs: natural products and their derivatives. – PubMed – NCBI
Washington University in St. Louis

Center for Research Innovation in Biotechnology
4240 Duncan Avenue, Suite 110
Saint Louis, MO 63110

(314) 747-1886

© 2020 Washington University in St. Louis | policies